The Effects of VEGF-B Signaling Pathway in Obesity and Metabolic Disease

计划入组 194 人 · 首次发布于 2017 年 5 月 23 日

Vascular Endothelial Growth Factor-B (VEGF-B) Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney Disease

计划入组 114 人 · 首次发布于 2020 年 6 月 5 日

Topical Bevacizumab for Preventing Recurrent Pterygium

计划入组 24 人 · 首次发布于 2011 年 3 月 10 日

AM-133

VEGF B cell peptide vaccine (cancer)

VEGF-B gene therapy(Zenyth Therapeutics)

AB&B BIO-TECH-B

B R B Software Systems Inc

United States

VIGONVITA-B

LaNova Medicines Initiates Phase 1 Trial of LM-299, Anti-PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors

Sozinibercept Shows Promise in Improving Visual Outcomes for nAMD Patients

Minghui Pharmaceutical's MHB039A Shows Promise in Phase I Trial for Solid Tumors